Cargando…

P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP-3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS

Detalles Bibliográficos
Autores principales:	El Chaer, Firas, Rein, Lindsay, Shimoda, Kazuya, Yuda, Junichiro, Haque, Tamanna, Mccloskey, James, Takami, Akiyoshi, Fukaya, Masafumi, Shirane, Shuichi, Kabir, Sujan, Mei, Jian, LI, Zhonggai, Wade, Mark, Lebedinsky, Claudia, Rampal, Raajit K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431443/ http://dx.doi.org/10.1097/01.HS9.0000971020.42358.df

Ejemplares similares

Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models
por: Dutta, Avik, et al.
Publicado: (2022)

The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
por: Wu, Chung-Pu, et al.
Publicado: (2021)

Biological drivers of clinical phenotype in myelofibrosis
por: Mascarenhas, John, et al.
Publicado: (2022)

Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
por: Verstovsek, Srdan, et al.
Publicado: (2021)

Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis
por: Gupta, Vikas, et al.
Publicado: (2023)

Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c Proteins Participate in the Suppression of Macrophage Apoptosis
por: Danelishvili, Lia, et al.
Publicado: (2010)

Comparative Analyses of 3,654 Plastid Genomes Unravel Insights Into Evolutionary Dynamics and Phylogenetic Discordance of Green Plants
por: Yang, Ting, et al.
Publicado: (2022)

P1044: REAL-WORLD RUXOLITINIB TREATMENT PATTERN IN MYELOFIBROSIS PATIENTS WITH THROMBOCYTOPENIA
por: Mei, J., et al.
Publicado: (2022)

Fibrocytes in primary myelofibrosis
por: Shimoda, Kazuya, et al.
Publicado: (2021)

Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
por: Verstovsek, Srdan, et al.
Publicado: (2016)

Sonate für Flöte und Cembalo Es-dur, BWV 1031 / H 545 = Sonata for flute and harpsichord in E flat major, BWV 1031 / H 545 /

LHC crab cavity specifications milestone: M10.3.1
por: Calaga, R, et al.
Publicado: (2010)

M10.3.1: LHC crab cavity specifications completed
por: Ciapala, E
Publicado: (2010)

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS
por: Bewersdorf, Jan, et al.
Publicado: (2023)

Recent advances in the diagnosis and management of primary myelofibrosis
por: Takenaka, Katsuto, et al.
Publicado: (2018)

P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SAFETY OF PELABRESIB (CPI-0610) AS ADD-ON TO RUXOLITINIB IN MYELOFIBROSIS
por: Kremyanskaya, Marina, et al.
Publicado: (2023)

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS
por: Harrison, Claire, et al.
Publicado: (2023)

SG-APSIC1031: Reappraisal of the effectiveness of a care bundle for patients with candidemia
por: Chen, Changhua, et al.
Publicado: (2023)

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
por: Mascarenhas, John, et al.
Publicado: (2023)

Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019)

The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis
por: Wolfe, Heather R., et al.
Publicado: (2022)

The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome
por: Yun, Ji-Hyun, et al.
Publicado: (2011)

Environmental and Occupational Respiratory Diseases – 1031. A study of outdoor aeroallergens in Riyadh, Saudi Arabia
por: Hasnain, Syed Mohammed, et al.
Publicado: (2013)

Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL
por: Zuluaga-Castaño, Yesica, et al.
Publicado: (2018)

TNF-α-1031T/C gene polymorphism as a predictor of malnutrition in patients with gastric cancer
por: Fu, Liang, et al.
Publicado: (2023)

P1027: UPDATED DURABILITY OF RESPONSE AND SAFETY IN MANIFEST ARM 3: PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB FOR JAK INHIBITOR TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS
por: Harrison, Claire, et al.
Publicado: (2023)

Myelofibrosis
por: Passamonti, Francesco, et al.
Publicado: (2023)

A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis
por: Pardanani, A, et al.
Publicado: (2015)

Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
por: Shide, Kotaro, et al.
Publicado: (2023)

Evaluation of 1031 primary titanium nitride coated mobile bearing total knee arthroplasties in an orthopedic clinic
por: Breugem, Stefan J M, et al.
Publicado: (2017)

1031 Comparative Epidemiology of Complicated Urinary Tract Infections (cUTI) by Age among US Hospitals
por: Mocarski, Michelle, et al.
Publicado: (2014)

An international comparability study on quantification of mRNA gene expression ratios: CCQM-P103.1
por: Devonshire, Alison S., et al.
Publicado: (2016)

The role of virtual reality on outcomes in rehabilitation of Parkinson’s disease: meta-analysis and systematic review in 1031 participants
por: Triegaardt, Joseph, et al.
Publicado: (2019)

Linac4 PIMS
por: Pantelia, Anna
Publicado: (2014)

Investigation of -308G>A and -1031T>C Polymorphisms in the TNFA Promoter Region in Polish Peptic Ulcer Patients
por: Sałagacka, Aleksandra, et al.
Publicado: (2014)

1031. Nationwide Temporal Trends of Candidemia Incidence Over 18 Years Within the Veteran Health Administration System
por: Suzuki, Hiroyuki, et al.
Publicado: (2018)

Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031
por: Sarr, Awa, et al.
Publicado: (2019)

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019)

1031. Mobility and Structural Barriers Contribute to Loss to Follow up from HIV Care in Rural South Africa
por: Hannaford, Alisse, et al.
Publicado: (2020)

Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients()
por: Teaima, Ahmed Abdelmoneim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t93fa661d54k7jguds0gnk61k5